Atlas Trials

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

Clinical trial NCT00754494 · COMPLETED

Trial details

NCT number
NCT00754494
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenomatous PolypRecurrent Colon CancerRecurrent Rectal CancerStage I Colon CancerStage I Rectal CancerStage IIA Colon CancerStage IIA Rectal CancerStage IIB Colon CancerStage IIB Rectal CancerStage IIC Colon CancerStage IIC Rectal CancerStage IIIA Colon Cancer
Start date
2008-07-01
Primary completion
2012-10-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.